Morales Concepción J C
Hospital Cmte. Manuel Fajardo, Ciudad de La Habana, Cuba.
Arch Esp Urol. 1992 Oct;45(8):793-5.
We report 16 cases of priapism in 13 of 404 patients who received intracavernous injection of vasoactive drugs to induce erection. In 10 patients the complication presented following injection of papaverine and phentolamine in combination. Despite reducing the dose of both agents, one patient had another episode of priapism. One patient who had been receiving papaverine alone in increasing doses with no results, developed priapism after the first injection of the combined treatment modality and again after the dose of both drugs had been reduced. Three cases presented priapism after injection with papaverine alone. One presented the complication again after injection of a reduced dose. The patients were seen after a sustained erection of 20 hours maximum on 15 occasions and one patient was seen after a sustained erection of 36 hours.
我们报告了404例接受海绵体内注射血管活性药物以诱导勃起的患者中有16例发生阴茎异常勃起,其中13例。10例患者在联合注射罂粟碱和酚妥拉明后出现该并发症。尽管两种药物的剂量都有所减少,但仍有1例患者再次发生阴茎异常勃起。1例患者一直单独使用递增剂量的罂粟碱但无效,在首次注射联合治疗方案后发生阴茎异常勃起,在两种药物剂量减少后又再次发作。3例患者在单独注射罂粟碱后出现阴茎异常勃起。1例患者在注射减量后再次出现该并发症。15例患者在阴茎持续勃起最长达20小时后前来就诊,1例患者在阴茎持续勃起36小时后前来就诊。